Intensity Therapeutics Common Stock Probability of Future Stock Price Finishing Over 0.4181
| INTS Stock | 0.42 0.01 2.77% |
Intensity | Build AI portfolio with Intensity Stock |
Intensity Therapeutics Target Price Odds to finish over 0.4181
The tendency of Intensity Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.42 | 90 days | 0.42 | about 50.0 |
Based on a normal probability distribution, the odds of Intensity Therapeutics to move above the current price in 90 days from now is about 50.0 (This Intensity Therapeutics Common probability density function shows the probability of Intensity Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Intensity Therapeutics Common has a beta of -0.53. This usually indicates as returns on the benchmark increase, returns on holding Intensity Therapeutics are expected to decrease at a much lower rate. During a bear market, however, Intensity Therapeutics Common is likely to outperform the market. In addition to that Intensity Therapeutics Common has an alpha of 4.6015, implying that it can generate a 4.6 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Intensity Therapeutics Price Density |
| Price |
Predictive Modules for Intensity Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Intensity Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Intensity Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intensity Therapeutics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Intensity Therapeutics is not an exception. The market had few large corrections towards the Intensity Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Intensity Therapeutics Common, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Intensity Therapeutics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 4.60 | |
β | Beta against Dow Jones | -0.53 | |
σ | Overall volatility | 0.15 | |
Ir | Information ratio | 0.09 |
Intensity Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Intensity Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Intensity Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Intensity Therapeutics is way too risky over 90 days horizon | |
| Intensity Therapeutics has some characteristics of a very speculative penny stock | |
| Intensity Therapeutics appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (16.27 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Intensity Therapeutics generates negative cash flow from operations | |
| Intensity Therapeutics has a poor financial position based on the latest SEC disclosures | |
| Latest headline from prnewswire.com: Intensity Therapeutics Highlights 2025 Milestones and Outlines 2026 Strategic Priorities |
Intensity Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Intensity Stock often depends not only on the future outlook of the current and potential Intensity Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Intensity Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 13.9 M | |
| Cash And Short Term Investments | 2.6 M |
Intensity Therapeutics Technical Analysis
Intensity Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Intensity Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Intensity Therapeutics Common. In general, you should focus on analyzing Intensity Stock price patterns and their correlations with different microeconomic environments and drivers.
Intensity Therapeutics Predictive Forecast Models
Intensity Therapeutics' time-series forecasting models is one of many Intensity Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Intensity Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Intensity Therapeutics
Checking the ongoing alerts about Intensity Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Intensity Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Intensity Therapeutics is way too risky over 90 days horizon | |
| Intensity Therapeutics has some characteristics of a very speculative penny stock | |
| Intensity Therapeutics appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (16.27 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Intensity Therapeutics generates negative cash flow from operations | |
| Intensity Therapeutics has a poor financial position based on the latest SEC disclosures | |
| Latest headline from prnewswire.com: Intensity Therapeutics Highlights 2025 Milestones and Outlines 2026 Strategic Priorities |
Additional Tools for Intensity Stock Analysis
When running Intensity Therapeutics' price analysis, check to measure Intensity Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intensity Therapeutics is operating at the current time. Most of Intensity Therapeutics' value examination focuses on studying past and present price action to predict the probability of Intensity Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intensity Therapeutics' price. Additionally, you may evaluate how the addition of Intensity Therapeutics to your portfolios can decrease your overall portfolio volatility.